Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $131.65
-
Support levelN/A
-
Resistance level$135.21
-
Beta0.3
-
RSI (14-day)31.9
- Volatility is forecast to fall over the next month.
- GILD is above its 200-day moving average, providing a measure of support for long positions.
- Price broke below prior support level - a short-term bearish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $96.91 | $155.80 | 64.5% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $126.80 | $140.33 | $135.57 | $131.44 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week6.3%
-
In the next month13.1%
-
In the next year55.0%
| Period | Value |
|---|---|
| Historical (5 year) | 23.7% |
| Last month | 25.2% |
| Current estimate | 23.0% |
| Next month forecast | 23.2% |